RecallHawk

VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE)

ASCENT PHARMS INC

Summary

FDA approved VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) by ASCENT PHARMS INC. ANDA (Generic) approval (Labeling) on 2023-05-24. TABLET, EXTENDED RELEASE, ORAL.

Details

Source

Drug Approval

External ID

ANDA214419-1

Action Date

2023-05-24

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

VENLAFAXINE HYDROCHLORIDE (generic: VENLAFAXINE), TABLET, EXTENDED RELEASE, ORAL. Application: ANDA214419

Context & Analysis

ASCENT PHARMS INC has 18 FDA actions in our database.

Frequently Asked Questions

How often does ASCENT PHARMS INC have FDA actions?

ASCENT PHARMS INC has 18 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA214419-1" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions